Communiqués Doseology Sciences Inc.

Actions

MOOD

CA2584842033

Produits pharmaceutiques

Marché Fermé - Canadian Securities Exchange 20:10:59 01/10/2026			Varia. 5j.	Varia. 1 janv.
0,1400 ^CAD	0,00%		-22,22%	-80,00%

30/09	Doseology Sciences Inc. annonce la nomination de membres à son conseil d’administration	CI
30/09	Doseology Sciences Inc. annonce un changement de directeur général	CI

Communiqués

30/09	Doseology Announces Director and Officer Changes; Completes Shares-for-Debt Settlement	AQ
24/09	Doseology Announces Proposed Shares-for-Debt Settlement and Resignation of Director	AQ
30/06	Doseology Announces Extension to Closing of Private Placement	AQ
16/05	Doseology Announces Extension to Closing of Private Placement and Resignation of Officer	AQ
30/03	Doseology Announces $2M Financing to Accelerate Commercialization of Oral Stimulant Pouch Platform	AQ
22/01	Doseology Begins Pilot Production of Caffeine-Based Energy Pouches as Feed that Brain(R) Enters Oral Stimulant Format	AQ
19/01	Doseology Files Annual Information Form (AIF), Strengthening Public Disclosure Record AIF Filing Enhances Transparency and Provides Consolidated Disclosure for Investors	AQ
24/12	The "New Vice" Economy: 5 Stocks Profiting from the Shift to Clean Fuel	AQ
01/12	Doseology Announces Launch of Corporate Communications Program	AQ
13/11	Doseology Completes Extensive North American Diligence, Securing Strategic Manufacturing Agreement via U.S. Subsidiary Doseology USA Inc.	AQ
27/08/25	Doseology Completes Acquisition of Feed That Brain™	AQ
19/08/25	Doseology Acquires Feed That Brain™ and Appoints Joseph Mimran as Strategic Advisor	AQ
17/07/25	Doseology Appoints Patrick W. Sills as Strategic Go-to-Market Advisor	AQ
12/06/25	Doseology Closes $750,000 Non-Brokered Private Placement	AQ
01/05/25	Doseology Announces Option Grant	AQ
25/04/25	Doseology Appoints Chris Jackson, Founder of Qtrade, as Chief Executive Officer and a Director	AQ
22/04/25	Doseology Provides Update on Offerings	AQ
04/03/25	Canadian Investment Regulatory Organization Trade Resumption - MOOD	AQ
04/03/25	Canadian Investment Regulatory Organization Trading Halt - MOOD	AQ
13/02/24	CSE Bulletin: Consolidation - Doseology Sciences Inc. (MOOD)	NE
27/09/23	Doseology Sciences : Failure to Satisfy Listing Rule - Form 8-K	PU
07/07/23	Doseology Sciences : Company Forms Lucy Discoveries Holdings for Future Research and Development - Form 8-K	PU
03/03/23	Doseology Welcomes New CFO	AQ
27/02/23	Lucy Scientific Discovery Announces First Commercial Sale of Psilocybin Following Initial Delivery of DMT and 5-MeO-DMT to Hadassah BrainLabs	GL
17/02/23	Doseology Sciences : Press release of Lucy Scientific Discovery Inc., dated February 16, 2023 - Form 8-K	PU